Adequate trials of NSAIDS for pain control

adequate trials of nonsteroidal antiinflammatory drugs for pain control

An analgesic should not be considered a failure unless it has been given an adequate trial. For non-cancer-related pain, 2 weeks of treatment with a maximum scheduled dose constitutes an adequate trial. For cancer-associated pain, a 1-week duration of continuous dosing is considered sufficient. However, ketorolac is not recommended for more than 5 days’ duration because of the risk of serious GI and other side effects.


Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information